Literature DB >> 18599799

Lipoprotein(a) is associated differentially with carotid stenosis, occlusion, and total plaque area.

Jonathan H Klein1, Robert A Hegele, Daniel G Hackam, Marlys L Koschinsky, Murray W Huff, J David Spence.   

Abstract

BACKGROUND: Lipoprotein(a) [Lp(a)] is a putative risk factor for myocardial infarction and stroke and is related to thrombosis and impaired fibrinolysis. We studied relationships of Lp(a) with carotid stenosis, occlusion, and total plaque area, distinct phenotypes of atherosclerosis that may be differentially affected by cardiovascular risk factors. METHODS AND
RESULTS: Multivariable linear regression analysis was used to study relationships of Lp(a) to phenotypes of carotid atherosclerosis among 876 consecutive patients from an atherosclerosis prevention clinic with complete data for all variables used in the model. Occlusion of an internal carotid artery was present in 22 (2.5%) patients (one with bilateral occlusions). Risk factors predicted carotid plaque area, stenosis, and occlusion differently. Lp(a) was a significant independent predictor of baseline stenosis (P<0.0001) but not of plaque area (P=0.13); in logistic regression, Lp(a) significantly predicted occlusion (P=0.001). Patients with occlusion had significantly higher levels of Lp(a): 0.27+/-0.25 g/L versus 0.17+/-0.18 g/L without occlusion; P=0.007.
CONCLUSIONS: Lp(a) was a significant independent predictor of carotid stenosis and occlusion, but not of carotid plaque area, supporting the hypothesis that the effect of Lp(a) on atherogenesis and cardiovascular risk is largely related to thrombosis and impaired fibrinolysis. Stenosis and occlusion may not be attributable to plaque progression, but to plaque rupture and thrombosis; this relationship may also apply to other arterial beds.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18599799     DOI: 10.1161/ATVBAHA.108.169292

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  17 in total

1.  Comparison of carotid plaque burden among healthy middle-aged men living in the US, Japan, and South Korea.

Authors:  Abhishek Vishnu; Jina Choo; Aya Kadota; Emma J M Barinas-Mitchell; Akira Fujiyoshi; Dorothy Leann Long; Takashi Hisamatsu; Vasudha Ahuja; Yasuyuki Nakamura; Rhobert W Evans; Katsuyuki Miura; Kamal H Masaki; Chol Shin; Hirotsugu Ueshima; Akira Sekikawa
Journal:  Int J Cardiol       Date:  2018-09-01       Impact factor: 4.164

2.  Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans.

Authors:  Fleur M van der Valk; Siroon Bekkering; Jeffrey Kroon; Calvin Yeang; Jan Van den Bossche; Jaap D van Buul; Amir Ravandi; Aart J Nederveen; Hein J Verberne; Corey Scipione; Max Nieuwdorp; Leo A B Joosten; Mihai G Netea; Marlys L Koschinsky; Joseph L Witztum; Sotirios Tsimikas; Niels P Riksen; Erik S G Stroes
Journal:  Circulation       Date:  2016-08-05       Impact factor: 29.690

Review 3.  Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.

Authors:  Børge G Nordestgaard; Anne Langsted
Journal:  J Lipid Res       Date:  2016-09-27       Impact factor: 5.922

4.  Genetic variation in LPAL2, LPA, and PLG predicts plasma lipoprotein(a) level and carotid artery disease risk.

Authors:  James Ronald; Ramakrishnan Rajagopalan; Felecia Cerrato; Alex S Nord; Thomas Hatsukami; Ted Kohler; Santica Marcovina; Patrick Heagerty; Gail P Jarvik
Journal:  Stroke       Date:  2010-12-02       Impact factor: 7.914

5.  Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  James F Meschia; Cheryl Bushnell; Bernadette Boden-Albala; Lynne T Braun; Dawn M Bravata; Seemant Chaturvedi; Mark A Creager; Robert H Eckel; Mitchell S V Elkind; Myriam Fornage; Larry B Goldstein; Steven M Greenberg; Susanna E Horvath; Costantino Iadecola; Edward C Jauch; Wesley S Moore; John A Wilson
Journal:  Stroke       Date:  2014-10-28       Impact factor: 7.914

6.  Race-Based Differences in Lipoprotein(a)-Associated Risk of Carotid Atherosclerosis.

Authors:  Brian T Steffen; George Thanassoulis; Daniel Duprez; James H Stein; Amy B Karger; Mathew C Tattersall; Joel D Kaufman; Weihua Guan; Michael Y Tsai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-03       Impact factor: 8.311

7.  Lipids and carotid plaque in the Northern Manhattan Study (NOMAS).

Authors:  Hannah Gardener; David Della Morte; Mitchell S V Elkind; Ralph L Sacco; Tatjana Rundek
Journal:  BMC Cardiovasc Disord       Date:  2009-12-22       Impact factor: 2.298

Review 8.  Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?

Authors:  Michael B Boffa; Marlys L Koschinsky
Journal:  J Lipid Res       Date:  2015-12-08       Impact factor: 5.922

9.  Effect of renal impairment on atherosclerosis: only partially mediated by homocysteine.

Authors:  J David Spence; Bradley L Urquhart; Heejung Bang
Journal:  Nephrol Dial Transplant       Date:  2015-11-14       Impact factor: 5.992

10.  Keloid scarring, but not Dupuytren's contracture, is associated with unexplained carotid atherosclerosis.

Authors:  Sankalp Bhavsar; Andre Nimigan; Daniel G Hackam; David B O'Gorman; Bing Siang Gan; J David Spence
Journal:  Clin Invest Med       Date:  2009-04-01       Impact factor: 0.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.